IFAH-Europe reaction to O’Neill report

Written by IFAH-Europe on 19 May 2016 in Press Release
Press Release

Brussels, 19 May 2016 – The final report of the O’Neill Review on Antimicrobial Resistance (AMR), released today, overall makes some good recommendations in terms of encouraging innovation for the quick development of new diagnostics, promoting the use of vaccines and alternatives to antibiotics, improving surveillance of AMR and antibiotic consumption in both people and animals, as well as endorsing better incentives to encourage investment for new medicines and improving existing ones, as well as the setting up of a Global Innovation Fund.


The animal health industry in Europe fully supports the proposal of a global public awareness campaign to be led by the UN General Assembly. The report could have gone further to acknowledge the work already done by the animal health sector in Europe for more than a decade through the awareness campaigns managed by the European Platform for the Responsible Use of Medicines in Animals - EPRUMA (www.epruma.eu) - which has been promoting responsible use of antibiotics in agriculture. These campaigns go hand in hand in with advocating excellent hygiene, biosecurity and good husbandry on farms. The idea of a global awareness campaign at UN level is to be lauded, but ultimately it must be aimed at the end-user, i.e. medical doctors and patients and vets and farmers. 

However, despite all these measures, infectious diseases in animals still naturally occur, and in the interest of animal health and welfare, antibiotics are vital to treat animals with a bacterial infection. We have a moral and legal obligation to safeguard the health and welfare of the animals in our care. This also impacts the food supply chain, as any animal that is not treated adequately due to a lack of options (e.g. no antibiotics available) will impact Europe’s food safety and security, as well as public health in the long run. The report could have seized the opportunity to mention that the goal of responsible use ultimately is to come to a use of antibiotics ‘as little as possible, as much as necessary’ – in other words, eliminate unnecessary and misuse of antibiotics on farms. 

There is a mention in the report of a possible tax on antibiotics in agriculture. Such a tax-based system on antibiotics could lead to sick animals not being treated which would impact animal welfare. Furthermore, on top of all the other uncertainties additional taxes would be a considerable disincentive for research and development in the antibiotic segment of the animal health industry. It would also contradict the report’s earlier encouragement for more investment and incentives in innovation as the way forward to fight AMR. 

Ultimately, antibiotics in animals and people need to be used more rationally and in a more targeted way, maximising the therapeutic effect and minimising the development of AMR (as is stated in the EC Guideline for Prudent Use of Antimicrobials in Animals (2015/ C 299/04) document), while safeguarding animal and public health and animal welfare. 

About the author

NOTE TO EDITORS: IFAH-Europe is the representative body of manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It represents innovators and generics alike, as well as large, medium-sized and small companies. IFAH-Europe promotes a single market in veterinary medicines across the EU ensuring the availability of medicines to protect the health and welfare of animals.  Follow IFAH-Europe on @IFAHEurope  - Like us on Facebook: www.facebook.com/WeCare.petsEurope

For further press information please contact                             
Kim Hardie, Communications Director
Tel.: +32 2 543 75 75                                                      
E-mail: k.hardie@ifahsec.org

Share this page



Partner content

This content is published by the Parliament Magazine on behalf of our partners.

Related Partner Content

New rules breaking down barriers to innovation in animal health
21 March 2018

As trilogue negotiations progress, there are numerous ways in which the new rules on animal medicines can shape up to deliver on objectives to foster innovation for improving the health and...

Inhumane inaction on pharmaceutical pollution
7 September 2018

The release of pharmaceuticals into the environment has significant detrimental effects on human health, write Sirpa Kärenlampi and Angelica Lindsey-Clark.

Helping European consumers to make informed nutritional choices
7 December 2018

Expanding ‘traffic light’ labelling trials across Europe can help build consumer awareness around this well-established nutritional information scheme, explains PepsiCo’s Silviu Popovici.